Testing a Personally Controlled Health Record to Ameliorate Influenza at MIT (Indivo at MIT)

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00531700
First received: September 18, 2007
Last updated: April 30, 2009
Last verified: April 2009
  Purpose

The purpose of this project is to evaluate the effects on influenza related knowledge, attitudes and behaviors of exposure to tailored/targeted health messages and contextualized information about influenza like illness delivered to subjects through a personally controlled health record system. The main study hypothesis is that exposure to more intensive levels of personalized and contextualized information about risk will result in increased knowledge about influenza, greater attributions of immunization safety and efficacy, improved health protecting behaviors including higher levels of appropriate immunization.


Condition Intervention
Influenza
Other: Health messaging
Other: Health messages

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Test of the PING/INDIVO Personal Health Record System at MIT

Resource links provided by NLM:


Further study details as provided by Children's Hospital Boston:

Primary Outcome Measures:
  • appropriate immunization behavior [ Time Frame: six months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • reduced presenteeism for school and work [ Time Frame: six months ] [ Designated as safety issue: Yes ]
  • appropriate immunization behaviors for close household/family members [ Time Frame: six months ] [ Designated as safety issue: Yes ]
  • knowledge about influenza and beliefs about influenza risk and transmission [ Time Frame: six months ] [ Designated as safety issue: No ]

Estimated Enrollment: 800
Study Start Date: October 2007
Study Completion Date: January 2009
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: I
Exposure to both tailored/targeted health messages about influenza and also to reports about contextualized influenza risk
Other: Health messaging
Combinations of personalized health messages (tailored/targeted) and contextualized health messages (reports about localized epidemiologic risk) will be delivered to subjects
Experimental: II
Exposure to tailored/targeted health messages
Other: Health messaging
Combinations of personalized health messages (tailored/targeted) and contextualized health messages (reports about localized epidemiologic risk) will be delivered to subjects
Experimental: III
Exposure to reports about influenza related contextualized risk
Other: Health messaging
Combinations of personalized health messages (tailored/targeted) and contextualized health messages (reports about localized epidemiologic risk) will be delivered to subjects
Active Comparator: IV
Comparison group exposed to community level health promotion messages not generated by the study
Other: Health messages
community level health messages unrelated to the study originating exposures

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages 18 and over
  • English speaker
  • Affiliated with study site

Exclusion Criteria:

  • Younger than 18
  • No access to computers or the internet
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00531700

Locations
United States, Massachusetts
Children's Hospital Boston
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Children's Hospital Boston
Investigators
Principal Investigator: Elissa R Weitzman Children's Hospital Boston
Principal Investigator: Kenneth D Mandl Children's Hospital Boston
  More Information

No publications provided

Responsible Party: Elissa R. Weitzman, Children's Hospital Boston
ClinicalTrials.gov Identifier: NCT00531700     History of Changes
Other Study ID Numbers: 06-07-0347
Study First Received: September 18, 2007
Last Updated: April 30, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
influenza
risk behaviors
immunization
knowledge attitudes behaviors
personally controlled health record
Indivo

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 18, 2014